Physician profile
John James Griffith
NPI 1578805164
$561.73
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $346 · 2021: $32.77 · 2022: $76.22 · 2023: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $107.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $149.44 | 2019-2022 | |
| Astellas Pharma US INC | $101.26 | 2019 | |
| Allergan, INC. | $53.09 | 2019 | |
| Sumitomo Pharma America, INC. | $47.00 | 2023 | Gemtesa |
| Dentsply Ih Ab | $41.51 | 2023 | Lofric |
| Urovant Sciences INC | $38.54 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $36.59 | 2019 | |
| Boston Scientific Corporation | $36.31 | 2019-2021 | |
| Acerus Pharmaceuticals Corporation | $22.97 | 2022 | |
| Photocure INC | $18.61 | 2023 | Cysview |
| Endo Pharmaceuticals INC. | $16.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.